# Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System

> **NCT02787928** · PHASE1 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 14 (actual)

## Conditions studied

- Cesarean Section
- Obstetric Anesthesia

## Interventions

- **DRUG:** Intrathecal hydromorphone

## Key facts

- **NCT ID:** NCT02787928
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Lack of reliable supply of of preservative free IV Hydromorphone for intrathecal use.
- **Last updated:** 2018-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787928, "Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02787928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*